Andre Hoekema retired in 2023 from Galapagos N.V. (Euronext and NASDAQ: GLPG) where he was the former Chief Business Officer since 2005, overseeing M&A, pharma partnering and IP.  Over his forty-plus year biotech career Mr. Hoekema held positions at Invitrogen Corporation (MD Corporate Development Europe), Crucell (Business Development), DSM Life Sciences and Syngenta MOGEN (Research and Project Management) and Genentech Inc. (Research Scientist).  Mr Hoekema received a masters and PhD from Leiden University and has authored over 30 peer-reviewed articles and is the inventor of over 20 series of issued patents. Mr. Hoekema also serves as a member of the supervisory boards of biotech start-up companies Fibrocor (Canada), and Mimetas BV and Sapreme BV (both located in Holland).